1.17
Finanzdaten der Hcw Biologics Inc-Aktie (HCWB)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
98.13%
0.1217
|
6.50 | 0.027 | 0.0156 | 0.00655 |
| Cost Of Revenue |
1,973%
0.2295
|
0.0111 | 0.0216 | 0.0125 | 0.00524 |
| Gross Profit |
101.44%
-0.0939
|
6.5319 | 0.0054 | 0.00312 | 0.00131 |
| Operating Expenses |
6.79%
3.0724
|
3.2962 | 4.4672 | 3.2952 | 3.4654 |
| Interest Income/Expense |
7.99%
0.1005
|
0.1093 | 0.2121 | 0.1271 | 0.2287 |
| Operating Income/Loss |
197.85%
-3.1663
|
3.2357 | -4.4618 | -3.2921 | -3.4641 |
| Income/Loss From Continuing Operations Before Tax |
237.25%
-5.2192
|
3.8027 | - | 0.0156 | -1.9277 |
| Income Tax Expense/Benefit |
100.00%
-
|
0.3302 | - | - | - |
|
|
250.30%
-5.2192
|
3.4725 | 0.7192 | -4.5543 | -1.9277 |
| Basic Average Shares |
46.85%
1.328
|
0.9043 | - | 2.2601 | 1.7801 |
| Diluted Average Shares |
46.85%
1.328
|
0.9043 | - | 2.2601 | 1.7801 |
| Basic Earnings Per Share |
933.09%
-11.58
|
1.39 | - | -2.02 | -6.79 |
| Diluted Earnings Per Share |
933.09%
-11.58
|
1.39 | - | -2.02 | -6.79 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):